1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow capcitabine: new trials by email Literature Review of capcitabine trials Research Report on capcitabine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma CRB-701, capcitabine, Cetuximab (EGFR inhibitor) - Oropharyngeal Carcinoma (OPC) | Phase 3 | Recruiting | Corbus Pharmaceuticals Inc. | 260 | 2026-09-29 | 2026-10-08 |
Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Corbus Pharmaceuticals Inc. (1)
Austria (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Portugal (1) · Romania (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
Ari Rosenberg, MD (1) · Cesar Peres, MD (1) · Pablo Nenclares, MD (1)